A.forall Launches Fifth ANDA, Gets Second First-Cycle FDA Approval
25 Jul 2024 //
BUSINESSWIRE
A.forall Announces Launch of a Generic Version of Sodium Acetate Injection
09 Jan 2024 //
BUSINESSWIRE
25 Jul 2024 //
BUSINESSWIRE
09 Jan 2024 //
BUSINESSWIRE